203 related articles for article (PubMed ID: 25981337)
1. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model.
Muhanna N; Mepham A; Mohamadi RM; Chan H; Khan T; Akens M; Besant JD; Irish J; Kelley SO
Nanomedicine; 2015 Oct; 11(7):1613-20. PubMed ID: 25981337
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
3. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J
BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response.
Satelli A; Brownlee Z; Mitra A; Meng QH; Li S
Clin Chem; 2015 Jan; 61(1):259-66. PubMed ID: 25336717
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
6. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
7. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
Johnson ES; Anand RK; Chiu DT
Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
[TBL] [Abstract][Full Text] [Related]
8. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
9. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
10. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
[TBL] [Abstract][Full Text] [Related]
11. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
[TBL] [Abstract][Full Text] [Related]
12. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation.
Gabriel MT; Calleja LR; Chalopin A; Ory B; Heymann D
Clin Chem; 2016 Apr; 62(4):571-81. PubMed ID: 26896446
[TBL] [Abstract][Full Text] [Related]
13. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
14. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract][Full Text] [Related]
15. Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences.
Gires O; Stoecklein NH
Cell Mol Life Sci; 2014 Nov; 71(22):4393-402. PubMed ID: 25103341
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-mediated binning and profiling of heterogeneous circulating tumor cell subpopulations.
Mohamadi RM; Besant JD; Mepham A; Green B; Mahmoudian L; Gibbs T; Ivanov I; Malvea A; Stojcic J; Allan AL; Lowes LE; Sargent EH; Nam RK; Kelley SO
Angew Chem Int Ed Engl; 2015 Jan; 54(1):139-43. PubMed ID: 25377874
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
Kelley RK; Magbanua MJ; Butler TM; Collisson EA; Hwang J; Sidiropoulos N; Evason K; McWhirter RM; Hameed B; Wayne EM; Yao FY; Venook AP; Park JW
BMC Cancer; 2015 Mar; 15():206. PubMed ID: 25884197
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
[TBL] [Abstract][Full Text] [Related]
19. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
[TBL] [Abstract][Full Text] [Related]
20. MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment.
Lapin M; Tjensvoll K; Oltedal S; Buhl T; Gilje B; Smaaland R; Nordgård O
Sci Rep; 2016 Jul; 6():28929. PubMed ID: 27432216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
